ZONHONBIO's focus in the field of oncology treatment is the development of innovative targeted immunotherapies for cancer that have clinical value and demonstrate differentiation or global leadership. Based on our distinctive platform, we design drugs that offer advantages in terms of safety, convenience, and compliance. We also independently develop companion diagnostic products that guide tumor diagnosis and treatment, providing clinical diagnostic evidence for precision medicine and exploring better treatment options for cancer patients worldwide.